Nuclear Medicine: Page 38

PET recommended over bone scintigraphy in pediatric sarcoma
By Will Morton
PET imaging is more effective than bone scintigraphy for detecting metastatic disease in children with soft-tissue cancer, according to a study published online August 9 in the European Journal of Cancer.
August 12, 2021
2016 09 27 14 38 54 774 Diverse Children 400
FDG-PET/CT predicts severity of COVID-19 infection
By Will Morton
FDG-PET/CT imaging in patients diagnosed with COVID-19 is associated with a higher risk of symptomatic infection and hospitalization, which may help predict disease severity, according to a study published August 8 in Clinical Imaging.
August 10, 2021
2021 08 10 23 24 4063 2021 08 11 Fdg Cancer Covid 19 20210810231936
Q BioMed signs Canadian distributor for Strontium89
By AuntMinnie.com staff writers
Biotech company Q BioMed has signed an exclusive distribution agreement for its Strontium89 therapeutic radiopharmaceutical with Canadian distributor isoSolutions Marketing & Management.
August 9, 2021
2020 02 13 23 07 2752 Q Bio Med Strontium89 400
GE set to supply iodine-123 to NorthStar
By AuntMinnie.com staff writers
GE Healthcare has inked an exclusive manufacturing and distribution agreement with NorthStar Medical Radioisotopes to manufacture and distribute iodine-123 capsules in the U.S.
August 2, 2021
2019 12 19 00 53 5252 Hands Shaking Deal 400
ImaginAb signs new agreement with Boehringer Ingelheim
By AuntMinnie.com staff writers
ImaginAb has signed a new license agreement to supply its ImmunoPET radiotracer to Boehringer Ingelheim.
July 22, 2021
2020 04 22 17 11 4900 Business Handshake Man 400
International Isotopes snaps up remaining RadQual shares
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes has purchased all remaining shares in its subsidiary RadQual, completing a transaction that began in 2017.
July 11, 2021
2019 11 13 00 46 2926 Business Deal Corporate 400
FDG-PET identifies biomarkers in dementia with Lewy bodies
By Will Morton
FDG-PET can identify whether mild cognitive impairment is associated with dementia with Lewy bodies or with Alzheimer's disease, two neurodegenerative conditions that can be indistinguishable in later stages, according to a study published July 4 in NeuroImage: Clinical.
July 7, 2021
2021 07 07 19 56 1327 2021 07 08 Mci Lewis Bodies Alz 20210707192716
Ga-68 PSMA-11 improves outcomes in prostate cancer patients
By Will Morton
PET with a gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA)-11 radiotracer should be the standard imaging modality for guiding stereotactic ablative radiotherapy in oligometastatic prostate cancer patients, according to a June 29 study in Clinical and Translational Radiation Oncology.
July 1, 2021
2021 01 16 00 14 5464 Prostate Cancer 400
AuntMinnie.com Molecular Imaging Insider
By Will Morton
June 29, 2021
Tau PET bests amyloid PET, MRI in Alzheimer's prognostic study
By Will Morton
Tau PET is superior to amyloid PET and MRI for detecting cognitive decline in Alzheimer's disease patients over time and may serve as a prognostic tool to help manage patients in the early stages of the disease, according to a study published June 28 in JAMA Neurology.
June 28, 2021
2018 07 24 00 33 7964 Brain 400
RayzeBio, Nimble ink research collaboration
By AuntMinnie.com staff writers
RayzeBio and Nimble Therapeutics plan to collaborate on the discovery and development of novel peptide-based radiopharmaceuticals for cancer treatment.
June 27, 2021
2020 04 22 17 11 4900 Business Handshake Man 400
Telix, Monrol reach agreement on therapeutic isotope supply
By AuntMinnie.com staff writers
Telix Pharmaceuticals has signed a global clinical supply agreement with Istanbul-based Eczacıbaşı-Monrol Nuclear Products (Monrol) for the supply of no-carrier-added lutetium-177, a therapeutic isotope used in Telix's portfolio of molecularly targeted radiation products.
June 27, 2021
2019 11 11 22 17 5854 Arrows Join Partner 400
Previous Page
Page 38 of 445
Next Page